Moridani MY - Search Results

1

Abdollahi M, Moridani MY, Aruoma OI, Mostafalou S. Abdollahi M, et al. Among authors: moridani my. Oxid Med Cell Longev. 2014;2014:876834. doi: 10.1155/2014/876834. Epub 2014 Apr 6. Oxid Med Cell Longev. 2014. PMID: 24803986 Free PMC article. No abstract available.

2

The importance of including topics related to pharmacogenetics, pharmacogenomics, and medical genetics in the pharmacy curriculum.

Harirforoosh S, Fleckenstein L, Mahajan P, Aruoma OI, Huang Y, Moridani M. Harirforoosh S, et al. Am J Pharm Educ. 2009 Oct 1;73(6):114. Am J Pharm Educ. 2009. PMID: 19885085 Free PMC article. No abstract available.

3

Efficacy of acetylsalicylic acid (aspirin) in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.

Vad NM, Kudugunti SK, Wang H, Bhat GJ, Moridani MY. Vad NM, et al. Among authors: moridani my. Tumour Biol. 2014 May;35(5):4967-76. doi: 10.1007/s13277-014-1654-1. Epub 2014 Feb 4. Tumour Biol. 2014. PMID: 24492939

4

Biochemical mechanism of acetaminophen (APAP) induced toxicity in melanoma cell lines.

Vad NM, Yount G, Moore D, Weidanz J, Moridani MY. Vad NM, et al. Among authors: moridani my. J Pharm Sci. 2009 Apr;98(4):1409-25. doi: 10.1002/jps.21505. J Pharm Sci. 2009. PMID: 18759348 Free PMC article.

5

Metabolic bioactivation and toxicity of ethyl 4-hydroxybenzoate in human SK-MEL-28 melanoma cells.

Vad NM, Shaik IH, Mehvar R, Moridani MY. Vad NM, et al. Among authors: moridani my. J Pharm Sci. 2008 May;97(5):1934-45. doi: 10.1002/jps.21107. J Pharm Sci. 2008. PMID: 17847068

6

Biochemical mechanism of acetylsalicylic acid (Aspirin) selective toxicity toward melanoma cell lines.

Vad NM, Yount G, Moridani MY. Vad NM, et al. Among authors: moridani my. Melanoma Res. 2008 Dec;18(6):386-99. doi: 10.1097/CMR.0b013e3283107df7. Melanoma Res. 2008. PMID: 18971789

7

Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.

Vad NM, Kudugunti SK, Graber D, Bailey N, Srivenugopal K, Moridani MY. Vad NM, et al. Among authors: moridani my. Int J Oncol. 2009 Jul;35(1):193-204. doi: 10.3892/ijo_00000329. Int J Oncol. 2009. PMID: 19513568

8

Structure-toxicity relationship of phenolic analogs as anti-melanoma agents: an enzyme directed prodrug approach.

Vad NM, Kandala PK, Srivastava SK, Moridani MY. Vad NM, et al. Among authors: moridani my. Chem Biol Interact. 2010 Feb 12;183(3):462-71. doi: 10.1016/j.cbi.2009.11.020. Epub 2009 Nov 26. Chem Biol Interact. 2010. PMID: 19944085 Free PMC article.

9

AAPS-FIP summary workshop report: Pharmacogenetics in individualized medicine: methods, regulatory, and clinical applications.

Moridani M, Maitland-van der Zee AH, Sasaki H, McKinnon R, Fleckenstein L, Shah VP. Moridani M, et al. AAPS J. 2009 Jun;11(2):214-6. doi: 10.1208/s12248-009-9097-0. Epub 2009 Mar 25. AAPS J. 2009. PMID: 19319689 Free PMC article.

10

Drug development and discovery: challenges and opportunities.

Moridani M, Harirforoosh S. Moridani M, et al. Drug Discov Today. 2014 Nov;19(11):1679-1681. doi: 10.1016/j.drudis.2014.06.003. Epub 2014 Jun 10. Drug Discov Today. 2014. PMID: 24928030 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page